Jiangsu Aidea Pharmaceutical Co Ltd Capital Reinvestment Ratio
Jiangsu Aidea Pharmaceutical Co Ltd capital reinvestment ratio. Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Capital Reinvestment Ratio of 0.51x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥3.56 Million) in capital expenditures (CN¥1.81 Million). See cash generation quality of Jiangsu Aidea Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
Capital reinvestment ratio of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. This chart tracks Jiangsu Aidea Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 4 annual periods. See 688488 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Jiangsu Aidea Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2016–2025)
Jiangsu Aidea Pharmaceutical Co Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Jiangsu Aidea Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.72x | CN¥17.63 Million | CN¥47.93 Million | ▲ +259.9% |
| 2020 | 0.76x | CN¥56.17 Million | CN¥42.43 Million | ▲ +26.7% |
| 2019 | 0.60x | CN¥56.20 Million | CN¥33.50 Million | ▼ -73.7% |
| 2016 | 2.27x | CN¥31.29 Million | CN¥71.01 Million | — |